Diaceutics - Capital Markets Event

Diaceutics PLC

14 May 2024

 

Diaceutics - Capital Markets Event - Wednesday, 12 June 2024

Belfast and London, 14 May 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, will host a virtual Capital Markets Event for analysts and investors on Wednesday, 12 June 2024 at 1400-1600 BST (0900-1100 ET). 

The event will include presentations from senior Diaceutics managers and partners. The purpose of the event will be to give analysts and investors a deeper insight into the DXRX platform, its functionality and hear from partners as to how they use the platform to find patients.

Those wishing to attend can register using the following link:

https://us02web.zoom.us/webinar/register/WN_WNsaZ-s8SfauitOYaWjdLA

Enquiries: 

Diaceutics PLC
Ryan Keeling, Chief Executive Officer   Nick Roberts, Chief Financial Officer	Tel: [phone] [e-mail]
Stifel Nicolaus Europe Limited (Nomad & Broker)	Tel: [phone]
Ben Maddison
Nick Harland
Kate Hanshaw
Alma Strategic Communications	Tel: [phone]
Caroline Forde Kinvara Verdon Kieran Breheny	[e-mail]

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.

We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.

 

END